Benigno, Yolanda .
HRN: 09-83-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2025
METRONIDAZOLE 500MG (TAB)
10/11/2025
10/17/2025
ORAL
500mg
TID
S/P VBAC With RMLE And Repair, Thickly MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes